Frandsen, Christian S. et al
"Twelve-Week Treatment With Liraglutide as Add-on to Insulin in Normal-Weight Patients With Poorly Controlled Type 1 Diabetes: A Randomized, Placebo-Controlled, Double-Blind Parallel Study." Diabetes Care
38.12
(2015):
2250-2257.
Web. 02 Mar. 2021.
